Breast cancer care during a pandemic: an opportune time for cryoablation? Dennis R. Holmes Editorial Open access 11 June 2020 Pages: 515 - 521
The bottom line for lesion localization in breast cancer M. Ahmed Editorial 13 June 2020 Pages: 523 - 525
Purposeful surgical delay and the coronavirus pandemic: how will black breast cancer patients fare? Samilia Obeng-GyasiBridget OppongMaryam Lustberg Editorial 16 June 2020 Pages: 527 - 530
The influence of mastectomy and reconstruction on residual upper limb function in breast cancer survivors Meghan E. VidtJohn PotochnyKathryn H. Schmitz Review 06 June 2020 Pages: 531 - 541
Meta-analysis of prepectoral implant-based breast reconstruction: guide to patient selection and current outcomes Olivia AbbateNikki RosadoEric C. Liao Review 09 June 2020 Pages: 543 - 554
Hormone replacement therapy and mammographic density: a systematic literature review Shadi AzamKatja Kemp JacobsenZorana Jovanovic Andersen Review Open access 22 June 2020 Pages: 555 - 579
The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes Maryam AlthobitiAbir A. MuftahEmad Rakha Preclinical study Open access 10 June 2020 Pages: 581 - 589
PIBF1 suppresses the ATR/CHK1 signaling pathway and promotes proliferation and motility of triple-negative breast cancer cells Eun Ji RoSeung-Hee RyuSang-Wook Lee Preclinical study 11 June 2020 Pages: 591 - 600
ETS transcription factor ESE-1/Elf3 is an independent prognostic factor of survival in HR+HER2+ breast cancer patients Adwitiya KarKaren KotoArthur Gutierrez-Hartmann Preclinical study 19 June 2020 Pages: 601 - 612
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer Roberto A. Leon-FerreEdith A. PerezAlvaro Moreno-Aspitia Clinical trial 05 June 2020 Pages: 613 - 622
The effect of 1-day multidisciplinary clinic on breast cancer treatment Zohaib AkhtarVered StearnsMehran Habibi Clinical Trial 08 June 2020 Pages: 623 - 629
The association of body composition parameters and adverse events in women receiving chemotherapy for early breast cancer G. F. P. AleixoS. S. ShacharG. R. Williams Clinical trial 09 June 2020 Pages: 631 - 642
A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns Anna-Karin TzikasSzilard NemesBarbro K. Linderholm Clinical trial Open access 10 June 2020 Pages: 643 - 654
Chronic adverse effects after an axillary lymphadenectomy in breast cancer patients after administering weaker and stronger postoperative analgesia: results of a prospective double-blind randomized study Nikola BesicJaka SmrekarBranka Strazisar Clinical trial 18 June 2020 Pages: 655 - 663
Plasma DNA as a “liquid biopsy” incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer Mary D. ChamberlinJason D. WellsTodd W. Miller Clinical trial 19 June 2020 Pages: 665 - 677
High-Efficiency Same-Day Approach to Breast Reconstruction During the COVID-19 Crisis Michelle SpechtNikhil SobtiEric C. Liao Clinical trial 19 June 2020 Pages: 679 - 688
Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): a phase III, randomized, double-blind, placebo-controlled study Binghe XuWei LiEleonora Restuccia Clinical trial Open access 20 June 2020 Pages: 689 - 697
Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study Anna PlymAnna L. V. JohanssonMats Lambe Epidemiology Open access 06 June 2020 Pages: 699 - 707
Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands E. HeegM. B. JensenM. T. F. D. Vrancken Peeters Epidemiology Open access 10 June 2020 Pages: 709 - 718
Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia Jinfeng ZhangMingxi LinXichun Hu Epidemiology 10 June 2020 Pages: 719 - 726
A 15-year follow-up study on long-term adherence to health behaviour recommendations in women diagnosed with breast cancer Daniel N. TollosaElizabeth HollidayErica L. James Epidemiology 13 June 2020 Pages: 727 - 738
Genetic polymorphisms in DNA repair genes XRCC1 and 3 are associated with increased risk of breast cancer in Bangladeshi population Nupur Rani HowladerMd. Mostafizur RahmanMd. Mustafizur Rahman Epidemiology 19 June 2020 Pages: 739 - 750
Neoadjuvant chemotherapy modifies serum pyrrolidone carboxypeptidase specific activity in women with breast cancer and influences circulating levels of GnRH and gonadotropins María Jesús Ramírez-ExpósitoJosé Manuel Martínez-MartosMaría Pilar Carrera-González Brief Report 06 June 2020 Pages: 751 - 760
Surveillance, Epidemiology, and End Results program underestimates breast cancer-specific mortality after ductal carcinoma in situ diagnosis Thomas J. O’KeefeAnne M. Wallace Letter to the Editor 11 June 2020 Pages: 761 - 762
Re: Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients Rodrigo Goncalves Letter to the Editor 13 June 2020 Pages: 763 - 764
Correction to: Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort Angela S. ChengSamuel C. Y. LeungTorsten O. Nielsen Correction 20 June 2020 Pages: 765 - 765
